NCT07138001 2025-08-22Phase 2 Clinical Trial of KH617Chengdu Kanghong Pharmaceutical Group Co., Ltd.Phase 2 Not yet recruiting60 enrolled
NCT04521686 2025-06-27Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT03684811 2023-11-18A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 MutationNovo Nordisk A/SPhase 1/2 Completed93 enrolled 24 charts